G1 Therapeutics Inc

NASDAQ:GTHX   3:59:58 PM EDT
12.82
-0.04 (-0.31%)
Earnings Announcements

G1 Therapeutics Reports Q2 Loss Per Share $0.92

Published: 08/03/2022 11:03 GMT
G1 Therapeutics Inc (GTHX) - G1 Therapeutics Provides Second Quarter 2022 Financial Results and Operational Highlights.
Q2 Revenue $10.6 Million.
Q2 Revenue View $9.1 Million -- Refinitiv Ibes Data (analyst estimates).
Q2 Loss per Share $0.92.
Q2 Earnings per Share View $-1.02 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $23.33 Million
Adjusted EPS is expected to be -$0.67

Next Quarter Revenue Guidance is expected to be $15.22 Million
Next Quarter EPS Guidance is expected to be -$0.81

More details on our Analysts Page.